Table 3.
Resolution of symptoms of COVID-19
| Symptoms | Time to resolution of symptoms | Resolution of symptoms | |||||
|---|---|---|---|---|---|---|---|
| Treatment (n = 36) | Control (n = 36) | ||||||
| Median | (95%CI) | Median | (95%CI) | HRa | 95%CI | p-value | |
| All symptoms | 8 | (5–10) | 8 | (7–13) | 1.18 | (0.68 to 2.05) | 0.562 |
| Cough | 5 | (3–8) | 8 | (4–8) | 1.23 | (0.74 to 2.03) | 0.427 |
| Runny nose | 0 | (0–3) | 2 | (0–5) | 1.32 | (0.82 to 2.13) | 0.251 |
| Sore throat | 0 | (0–3) | 0 | (0–3) | 1.00 | (0.63 to 1.59) | 0.997 |
| Smell disturbance | 0 | (0–0) | 0 | (0–0) | 1.23 | (0.76 to 1.99) | 0.391 |
| Taste disturbance | 0 | (0–1) | 0 | (0–0) | 0.96 | (0.60 to 1.53) | 0.864 |
| Muscle pain | 0 | (0–1) | 0 | (0–0) | 0.81 | (0.50 to 1.31) | 0.388 |
| Headache | 0 | (0–0) | 0 | (0–0) | 1.25 | (0.78 to 2.02) | 0.354 |
| Fever | 0 | (0–1) | 0 | (0–1) | 0.90 | (0.57 to 1.43) | 0.650 |
| Dyspnea | 0 | (0–0) | 0 | (0–0) | 0.97 | (0.61 to 1.54) | 0.888 |
| Block nose | 0 | (0–0) | 0 | (0–0) | 1.08 | (0.68 to 1.73) | 0.733 |
| Diarrhea | 0 | (0–0) | 0 | (0–0) | 1.03 | (0.65 to 1.65) | 0.888 |
| Chest pain | 0 | (0–0) | 0 | (0–0) | 1.06 | (0.66 to 1.69) | 0.811 |
| Fatigue | 0 | (0–0) | 0 | (0–0) | 1.19 | (0.73 to 1.92) | 0.488 |
| Sneezing | 0 | (0–0) | 0 | (0–0) | 1.05 | (0.66 to 1.67) | 0.843 |
| Vomiting | 0 | (0–0) | 0 | (0–0) | 1.03 | (0.65 to 1.64) | 0.906 |
aHazard ratio for resolution of symptoms was estimated by the Cox proportional-hazard model